About 500 reports

  • Deal Type
  • Deal Type

GlobalData AZURRX BIOPHARMA INC REPORTED ONE PHARMACEUTICALS & HEALTHCARE DEAL WORTH $##. ## MILLION IN YTD 2018.

  • Biopharmaceutical
  • Pharmaceutical
  • Company
  • Corporate Finance
  • BioPharma company
  • Deal Type

It provides tests for infections of the bloodstream, respiratory tract and gastrointestinal tract.

  • Bionanotechnology
  • Medical Device
  • Nanobiotechnology
  • Corporate Finance
  • Nanosphere, Inc.
  • Deal Type

GlobalData Livzon Pharmaceutical Group Inc reported one pharmaceuticals & healthcare deal worth $##. ## million in YTD 2018.

  • Pharmaceutical
  • Company
  • Corporate Finance
  • Deals & Alliance
  • M&A

One study recruits children as young as one year old with a particularly aggressive form of neuroblastoma.

  • Pharmaceutical
  • United States
  • Corporate Finance
  • Product Initiative
  • Protalex, Inc.
  • Deal Type
  • Ventrus Biosciences Completes Public Offering Of Preferred Shares For US$5.5 Million

The company from time to time may issue common stock, preferred stock, debt securities, warrants and units in one or more offerings.

  • Pharmaceutical
  • United States
  • Company
  • Corporate Finance
  • Assembly Biosciences, Inc.
  • ENTEROMEDICS RAISES USD20 MILLION IN PUBLIC OFFERING OF UNITS
  • Deal Type

Each unit consists of one share of common stock and one series A warrant to purchase one share of common stock of par value USD##. ## per share, and one series A warrant to purchase one share of common stock.

  • Medical Device
  • Medical Equipment
  • United States
  • Corporate Finance
  • Market Shares

GlobalData Angion Biomedica Corp' s, deal volume increased from zero pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • United States
  • Company
  • Corporate Finance
  • Angion Biomedica Corp.

All Regado shares will be subject to the nine for one reverse stock split.

  • Therapy
  • United States
  • Company
  • Corporate Finance
  • Tobira Therapeutics, Inc.
  • XENOPORT COMPLETES PUBLIC OFFERING OF COMMON STOCK FOR US$46 MILLION
  • DEBT OFFERING

The company' s generic products are used for the treatment of conditions such as gastrointestinal disorders, oncology, cardiovascular diseases, pain management, Central Nervous System, cancer, pain, infectious diseases and pediatrics.

  • Healthcare
  • Pharmaceutical
  • Corporate Finance
  • Demand
  • XenoPort, Inc.
  • Deal Type

GlobalData is one of the world' s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally.

  • Healthcare
  • Pharmaceutical
  • Corporate Finance
  • Deals & Alliance
  • M&A

Each unit comprised of one common share and one warrant.

  • Ear Disease
  • Therapy
  • Company
  • Corporate Finance
  • Auris Medical Holding AG

Penta is one of significant players in the healthcare sector in the CEE.

  • Health Services
  • Corporate Finance
  • Deals & Alliance
  • M&A
  • Emc Instytut Medyczny SA
  • Relypsa Completes IPO For US$86.7 Million

Relypsa will fund the grant awards of up to $##, ## each for one academic year.

  • Healthcare
  • Pharmaceutical
  • Company
  • Corporate Finance
  • Relypsa, Inc.

The debentures bear an interest rate of ##% per annum payable monthly, and will mature on January ##, 2015.

  • Opioid
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Intellipharmaceutics International Inc.

The drug candidates selectively target microsomal prostaglandin E synthase-## (mPGES-##).

  • Pharmaceutical
  • Company Financials
  • Corporate Finance
  • Supply
  • Glenmark Pharmaceuticals Ltd.

The company reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Pharmaceutical
  • Company Financials
  • Corporate Finance
  • Deals & Alliance
  • TaiwanJ Pharmaceuticals Co., Ltd.

Gentamicin has become one of the most commonly prescribed hospital antibiotics, despite causing kidney toxicity.

  • Healthcare
  • Pharmaceutical
  • United States
  • Corporate Finance
  • La Jolla Pharmaceutical Company

Interest on the notes is payable semi-annually on April ## and October ## of each year, beginning from October ##, 2013.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Corporate Finance
  • Medtronic, Inc.

GlobalData is one of the world' s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally.

  • Healthcare
  • Pharmaceutical
  • Corporate Finance
  • Deals & Alliance
  • Pharmacyclics, Inc.

It inhibits hypoxia inducible factor ## (HIF-##) alpha and topoisomerase I.

  • Pharmaceutical
  • United States
  • Company
  • Corporate Finance
  • Cerulean

Each unit consists of one share of the company' s common stock and one warrant to purchase ##. ## of a share of common stock.

  • Healthcare
  • Therapy
  • Company
  • Corporate Finance
  • Pluristem Therapeutics Inc.

Pamrevlumab in Pancreatic Cancer Positive findings from an ongoing open-label, randomized Phase ##/ ## study in locally advanced pancreatic cancer were presented at the 2017 Gastrointestinal Cancers Symposium in January.

  • Blood Disease
  • Healthcare
  • Pharmaceutical
  • Corporate Finance
  • FibroGen, Inc.

The company reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Healthcare
  • Pharmaceutical
  • Company
  • Corporate Finance
  • Aquinox Pharmaceuticals, Inc.

Deal Rationale Medline Industries Inc (Medline) is one of the leading manufacturers and distributors of healthcare supplies in the US.

  • Ambulatory Care
  • Healthcare
  • Corporate Finance
  • Deals & Alliance
  • Surgical Care Affiliates, Inc.

Each Unit consists of one common share and one share purchase warrant.

  • Pharmaceutical
  • Therapy
  • Corporate Finance
  • M&A
  • Sunovion Pharmaceuticals Inc.

The drug was well tolerated during this one-year trial.

  • Pharmaceutical
  • Therapy
  • United States
  • Corporate Finance
  • Galectin Therapeutics Inc.

GlobalData Huons Global Co Ltd' s, deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Pharmaceutical
  • World
  • Corporate Finance
  • Deals & Alliance
  • Huons Global Co Ltd

GlobalData is one of the world' s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally.

  • Pharmaceutical
  • Company
  • Corporate Finance
  • M&A
  • Omega

The notes have a coupon rate of ##. ##% with a term period of one year.

  • Pharmaceutical
  • Corporate Finance
  • Deals & Alliance
  • M&A
  • Tasly Pharmaceutical Group Co., Ltd.

The company reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Pharmaceutical
  • United States
  • Company
  • Corporate Finance
  • Inotek Pharmaceuticals Corporation